Is Wegovy a Daily or Weekly Injection? Understanding the Dosing Schedule and Its Importance

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is given as a once-weekly subcutaneous injection, not a daily medication. This weekly dosing schedule was designed based on the medication's pharmacokinetics—its ability to remain active in your system for seven days—allowing your body steady access to the GLP-1 receptor activation it needs for appetite control and metabolic support.

Weekly Semaglutide Injections: How the Dosing Schedule Works

Semaglutide reaches peak blood concentration approximately 1–3 days after injection, then maintains therapeutic levels throughout the week before the next dose. This once-weekly delivery method simplifies adherence compared to daily oral medications, since you only need to remember one injection day per week. PlexusDx patients receive their semaglutide injections in pre-filled pens or syringes shipped directly to their homes, with clear instructions on injection timing and rotation sites.

The standard starting dose for semaglutide weight loss therapy is 0.25 mg weekly. Your healthcare provider may gradually increase your dose every 4 weeks—moving to 0.5 mg, 1 mg, 1.7 mg, and potentially 2.4 mg—based on your tolerability and clinical response. At PlexusDx, your dose may need to go up, but your price won't, because all semaglutide injection plans are priced at a flat monthly rate regardless of strength.

Why Weekly Injections Are Superior to Daily Dosing

Once-weekly dosing reduces the burden of daily pill-taking or injections, which research shows improves long-term medication compliance. Studies demonstrate that patients on weekly GLP-1 therapy maintain better weight loss outcomes when they don't miss doses, and the simpler schedule makes this achievable. Additionally, weekly injections create more stable blood levels of the medication compared to the peaks and troughs of daily dosing, which may reduce breakthrough hunger signals between doses.

The weekly format also aligns with the natural weekly rhythm many people use for meal planning, grocery shopping, and lifestyle management. Choosing a consistent day—such as Sunday morning or Wednesday evening—turns your injection into a weekly routine that becomes as habitual as checking your calendar. This behavioral anchoring improves adherence and helps sustain the metabolic benefits semaglutide provides.

Semaglutide Injection Timing: What Happens Between Doses

Between weekly injections, semaglutide gradually clears from your bloodstream while remaining therapeutically active. By day 7, plasma concentrations are approximately 50% of the peak level, which is still sufficient to support appetite suppression and improved blood sugar control. This extended half-life of roughly 7 days is why the medication was formulated for once-weekly use rather than more frequent dosing schedules.

If you accidentally miss a weekly injection, PlexusDx recommends contacting your care team for guidance. Depending on how many days have passed, your provider may advise taking your dose immediately or waiting until your next scheduled day if you're only 1–2 days late. Consistency matters: maintaining your regular weekly schedule prevents gaps in therapeutic coverage and keeps your appetite-control benefits steady.

Getting Started With PlexusDx Semaglutide Injections

PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies to all 50 states without requiring insurance or membership fees. Your plan is $189 per month month-to-month and remains the same whether you're on a starter dose or maintenance strength—no hidden increases as your dose adjusts. HSA and FSA accounts are eligible for use, making personalized semaglutide therapy more affordable.

After your first month of treatment, PlexusDx patients can add the Precision Peptide Genetic Test for $298. This peptide-pathway genetic assessment examines key variants like FTO rs9939609 to reveal your individual peptide sensitivities and metabolic predispositions. Understanding your genetic profile helps your PlexusDx provider fine-tune your dose schedule and compound selection for maximum results.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I switch from daily pills to weekly semaglutide injections?

Yes. If you're currently taking oral semaglutide or another weight loss medication, PlexusDx can transition you to weekly injectable semaglutide. The once-weekly format typically improves compliance and may enhance efficacy. Your PlexusDx provider will evaluate your current dose and health history to recommend the right starting strength.

What clinical evidence supports once-weekly semaglutide dosing?

Randomized controlled trials (including the STEP program) demonstrated that once-weekly semaglutide produced sustained weight loss of 10–22% depending on the final dose, with peak efficacy at 2.4 mg weekly. The weekly schedule was chosen because plasma half-life studies showed that a 7-day interval maintains stable therapeutic concentrations without requiring daily dosing.

Is PlexusDx semaglutide injection available in all states, and what is the cost?

PlexusDx serves all 50 states with no insurance requirement. Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and stay at that flat price across all dose levels. HSA and FSA funds are accepted, and there are no membership or shipping fees.

What are common side effects of weekly semaglutide injections?

The most frequent side effects include nausea, vomiting, constipation, and diarrhea, typically mild to moderate and most common when starting or increasing doses. Symptoms often improve as your body adjusts over 2–4 weeks. Serious side effects are rare but can include pancreatitis or gallbladder issues; contact your PlexusDx provider immediately if you experience severe abdominal pain.

How does the Precision Peptide Genetic Test help optimize my semaglutide schedule?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Injection Wegovy
• Tirzepatide Dosing Schedule Plexusdx
• Wegovy Injection Site
• Wegovy Injection

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.